Short answer: Menopur (menotropins) is purified from the urine of postmenopausal women and has both FSH and LH activity, 75 IU of each per vial; it is approved only for IVF-type cycles. Gonal-f (follitropin alfa) is lab-made FSH alone, in a prefilled pen, approved for IVF and for inducing ovulation.12 Two large IVF trials found similar ongoing pregnancy rates.
| Menopur (menotropins) | Gonal-f RFF Redi-ject (follitropin alfa) | |
|---|---|---|
| What it is | FSH and LH activity extracted from the urine of postmenopausal women and purified; hCG is also detected1 | FSH only, made by recombinant DNA technology in hamster ovary cells2 |
| Approved for | Growing multiple follicles in ovulatory women in an assisted reproduction (IVF) cycle1 | IVF-type cycles, and inducing ovulation in women who do not ovulate regularly2. The Gonal-f multi-dose kit is also approved for sperm production in some men3 |
| Form | Powder vials of 75 IU FSH and 75 IU LH, mixed with saline before injection; use right after mixing1 | Prefilled pen of 300, 450 or 900 IU, set in 12.5 IU steps2 |
| IVF starting dose (label) | 225 IU a day from cycle day 2 or 31 | 150 IU a day from cycle day 2 or 3; 225 IU in women 35 and older with suppressed hormones2 |
| IVF dose limits (label) | Adjust after 5 days, no more often than every 2 days, by up to 150 IU; no more than 450 IU a day or 20 days1 | Adjust after 5 days, no more often than every 3 to 5 days, by 75 to 150 IU; no more than 450 IU a day; usually up to 10 days2 |
| Half-life of FSH | 11 to 13 hours after repeated doses1 | About 53 hours after a single 300 IU dose2 |
| OHSS in its label IVF trial | 6.2% of 434 women1 | 4.6% of 237 women2 |
| Storage | Powder in the fridge or at room temperature (37°F to 77°F) until dispensed; protect from light1 | Fridge until expiry, or room temperature for up to 3 months; after first use, 28 days in the fridge or at room temperature2 |
| Missed dose | Do not double; call your provider1 | Do not double; call your provider2 |
Yes, as drug types. Two large randomized trials compared highly purified menotropin (the kind of product Menopur is) with recombinant FSH (the kind of drug Gonal-f is) in IVF cycles after a long GnRH agonist protocol. The abstracts do not name the recombinant brand.
The Menopur label reports the first trial's result as non-inferior to recombinant FSH.1
Menopur supplies LH activity along with FSH; Gonal-f supplies FSH only.12 MERiT reported differences between the two in follicle development, egg and embryo quality, hormone levels and the look of the uterine lining, which the authors said may matter for outcomes.5 Which products and doses fit your cycle is set by your fertility clinic.
The OHSS rates in the table come from each label's own trial, with different women and comparators, so they are not a head-to-head comparison.12
More detail: Menopur side effects, Gonal-f side effects, and the Menopur and Gonal-f dosing schedules.